Novartis India Ltd (NOVARTIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 333626, "name": "Novartis India", "stock_name": "Novartis India", "full_name": "Novartis India Ltd", "name_url": "stocks-analysis/novartis-india", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,112.60", "chg": 47.15, "chgp": "4.43%", "dir": 1, "prev_price": "1,065.45", "mcapval": "2,696.00 Cr", "mcap": "Small Cap", "scripcode": 500672, "symbol": "NOVARTIND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE234A01025", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "32.33 k", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Novartis India Ltd to 52-Week High of Rs 1116", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-hits-new-52-week-high-at-rs1116-3981445", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovartisIndiaLt_priceRelatedfactors_3981445.png", "date": "2026-05-08 10:15:18", "description": "Surging past its previous peaks, Novartis India Ltd touched a new 52-week high of Rs 1116 on 08 Jun 2026, marking a significant milestone in its price momentum. This advance comes amid a four-day consecutive gain, accumulating a 9.01% return over this period, and outpacing its sector by 4.62% on the day." }, { "title": "Novartis India Ltd Technical Momentum Shifts to Bullish Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-technical-momentum-shifts-to-bullish-amid-mixed-indicator-signals-3978723", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovartisIndiaLt_technicaldot_3978723.png", "date": "2026-05-07 08:01:37", "description": "Novartis India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key indicators such as the MACD and moving averages, despite some cautionary signs from the monthly RSI. Investors should weigh these mixed signals carefully as the stock navigates a critical phase in its price trajectory." }, { "title": "Novartis India Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3975204", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovartisIndiaLt_mojoScore_3975204.png", "date": "2026-05-05 08:27:49", "description": "Novartis India Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 4 May 2026. This revision follows a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a nuanced but cautious outlook despite some long-term strengths." }, { "title": "Novartis India Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3974704", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovartisIndiaLt_technicaldot_3974704.png", "date": "2026-05-05 08:01:43", "description": "Novartis India Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish trend, as reflected in recent market data and technical indicators. Despite a modest decline in the stock price, the underlying signals from MACD, RSI, and moving averages present a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Novartis India Gains 7.46%: 3 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-gains-746-3-key-factors-driving-the-weekly-rally-3971873", "imagepath": "", "date": "2026-05-03 09:00:43", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Stock opens at Rs.979.45, gaining 1.90%</p>\n <p><strong>28 Apr:</strong> Intraday high of Rs.1,046.40 with a 7.51% surge</p>\n <p><strong>29 Apr:</strong> Minor correction, closes at Rs.1,034.10 (-1.79%)</p>\n <p><strong>30 Apr:</strong> Upgraded to Hold; technical momentum shifts bullish</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.961.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,032.90</div><div cl..." }, { "title": "Novartis India Ltd Upgraded to Hold on Technical Improvements and Long-Term Growth", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-upgraded-to-hold-on-technical-improvements-and-long-term-growth-3969569", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovartisIndiaLt_mojoScore_3969569.png", "date": "2026-04-30 08:07:59", "description": "Novartis India Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and long-term financial trends despite recent quarterly setbacks. The pharmaceutical company’s technical outlook has shifted to bullish, supported by strong momentum in key moving averages and MACD signals, while its valuation and quality metrics present a mixed but cautiously optimistic picture for investors." }, { "title": "Novartis India Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-3969382", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovartisIndiaLt_technicaldot_3969382.png", "date": "2026-04-30 08:00:45", "description": "Novartis India Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a day’s decline of 1.79% to close at ₹1,034.10, the stock’s underlying technical indicators suggest strengthening momentum, supported by bullish signals from MACD, moving averages, and Bollinger Bands on weekly and monthly timeframes. However, mixed readings from RSI and KST indicators highlight areas of caution for investors navigating this pharmaceutical small-cap stock." }, { "title": "Novartis India Ltd Surges 7.51% to Day's High of Rs 1046.4 — Outperforms Sector by 5.04 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/novartis-india-ltd-hits-intraday-high-with-751-surge-on-28-apr-2026-3966711", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovartisIndiaLt_priceRelatedfactors_3966711.png", "date": "2026-04-28 13:01:01", "description": "The Sensex declined 0.47% on 28 Apr 2026, while Novartis India Ltd surged 7.51%, outperforming its Pharmaceuticals & Biotechnology sector by 5.04 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop." }, { "title": "Novartis India Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/novartis-india-ltd-is-rated-sell-3955937", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovartisIndiaLt_mojoScore_3955937.png", "date": "2026-04-21 10:10:03", "description": "Novartis India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most recent and relevant data to inform their decisions." } ], "total": 233, "sid": "333626", "stock_news_url": "https://www.marketsmojo.com/news/novartis-india-333626" }, "announcements": [ { "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A", "datetime": "23-Apr-2026", "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Novartis India Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24200MH1947PLC006104</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: CHANDNI MARU <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: india.investors@novartis.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: SHILPA JOSHI <br/> Designation: WHOLETIME DIRECTOR AND CHIEF FINANCIAL OFFICER <br/> EmailId: india.investors@novartis.com</div> </div> <div> <br/> Date: 23/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "17-Apr-2026", "details": "Intimation of Newspaper Advertisement by Novartis India Limited (the Company)- Completion of e-mailing of Notice of Postal Ballot to the Members of the Company.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot", "datetime": "16-Apr-2026", "details": "Notice of Postal Ballot - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 (Listing Regulations).", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "12 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 25", "dt": "2025-07-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Apr: Stock opens at Rs.979.45, gaining 1.90%

28 Apr: Intraday high of Rs.1,046.40 with a 7.51% surge

29 Apr: Minor correction, closes at Rs.1,034.10 (-1.79%)

30 Apr: Upgraded to Hold; technical momentum shifts bullish

Read full news article

Novartis India Ltd Upgraded to Hold on Technical Improvements and Long-Term Growth

2026-04-30 08:07:59

Novartis India Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and long-term financial trends despite recent quarterly setbacks. The pharmaceutical company’s technical outlook has shifted to bullish, supported by strong momentum in key moving averages and MACD signals, while its valuation and quality metrics present a mixed but cautiously optimistic picture for investors.

Read full news article

Novartis India Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators

2026-04-30 08:00:45

Novartis India Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a day’s decline of 1.79% to close at ₹1,034.10, the stock’s underlying technical indicators suggest strengthening momentum, supported by bullish signals from MACD, moving averages, and Bollinger Bands on weekly and monthly timeframes. However, mixed readings from RSI and KST indicators highlight areas of caution for investors navigating this pharmaceutical small-cap stock.

Read full news article

Novartis India Ltd Surges 7.51% to Day's High of Rs 1046.4 — Outperforms Sector by 5.04 Percentage Points

2026-04-28 13:01:01

The Sensex declined 0.47% on 28 Apr 2026, while Novartis India Ltd surged 7.51%, outperforming its Pharmaceuticals & Biotechnology sector by 5.04 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.

Read full news article

Novartis India Ltd is Rated Sell

2026-04-21 10:10:03

Novartis India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most recent and relevant data to inform their decisions.

Read full news article

Sr. No.	Particulars	Details
1	Name of Company	Novartis India Ltd
2	CIN NO.	L24200MH1947PLC006104
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	0.00
4	Highest Credit Rating during the previous FY	NA
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	Not Applicable
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE